What changed
$KR — BUY 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
🎯 FQ2 FY2027 (ends Jul) | reported Jun 18 | EPS $1.58 vs $1.46 🟢
💡 Consensus expected EPS of $1.46; actual $1.58 beat by 8.2%. The market prices KR at a single-digit P/E, implying earnings decline, but recent results point to a normalized $6+ annual EPS potential. The gap is that the market is too pessimistic about Kroger's earnings power.
📉 Reward/risk: 3.0:1
🏢 Business Quality: 5/10
📊 Valuation: cheap — trailing P/E 9.1x vs consumer staples average 15-20x and grocery peer range 10-14x.
🔮 Catalyst: Next quarterly earnings report and potential guidance raise
💰 Entry: $57.73, stop $52.0, target $75.0
⚖️ Buy KR at $57.73 for a 3:1 reward/risk on depressed expectations and an earnings beat catalyst, with a 6-month target of $75.